drugset / Trial / NCT00498160

Induction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell Infusion

NCT00498160 ↗

NaSingle-groupOpen-labelTreatment

Summary

The goal of this research study is to establish chimerism and avoid graft-versus-host disease in patients with kidney failure allowing a reduction or cessation of immune-suppressive therapy.

Timeline

Start
2005-01
Primary completion
2024-08
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Enriched Hematopoietic Stem Cell Infusion Cell therapy — —

Indications